Ridha Limame - Concepedia

Author

Ridha Limame

University of Antwerp ORCID

Also Known As

R Limame, R. Limame, Ridha Limame

Publications

Citations

H-Index

Concepts

All Affiliations

University of Antwerp Antwerp University Hospital Ghent University Hospital GZA Ziekenhuizen Campus Sint-Augustinus KU Leuven

About

Ridha Limame is an author at University of Antwerp specializing in health sciences, cancer cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	2	2	168
2	Medicine	2	2	168
3	Cell Biology	2	2	168
4	Natural Sciences	1	1	61
5	Biomolecular Engineering	1	1	61

Ridha Limame

Publications

885

Citations

H-Index

Page 1

	Year	Citations
Comparative Analysis of Dynamic Cell Viability, Migration and Invasion Assessments by Novel Real-Time Technology and Classic Endpoint Assays Ridha Limame, An Wouters, Bea Pauwels, PLoS ONE	2012	307
Cancer-Associated Adipose Tissue Promotes Breast Cancer Progression by Paracrine Oncostatin M and Jak/STAT3 Signaling Lore Lapeire, An Hendrix, Kathleen Lambein, Cancer Research Breast OncologyMolecular BiologyCancer BiologyTumor BiologySignaling Pathway	2014	139
Integrated miRNA and mRNA expression profiling of the inflammatory breast cancer subtype Ilse Van der Auwera, Ridha Limame, Peter A. van Dam, British Journal of Cancer	2010	130
Overcoming cetuximab resistance in HNSCC: The role of AURKB and DUSP proteins Carolien Boeckx, Ken Op de Beeck, An Wouters, Cancer Letters Protein FunctionNatural SciencesMolecular BiologyCetuximab ResistanceDusp Proteins	2014	61
Quantitative methylation profiling in tumor and matched morphologically normal tissues from breast cancer patients Ilse Van der Auwera, Catherine Bovie, Cecilia Svensson, BMC Cancer	2010	49
Differential regulation of extracellular matrix protein expression in carcinoma-associated fibroblasts by TGF-β1 regulates cancer cell spreading but not adhesion Mieke Van Bockstal, Kathleen Lambein, Mireille Van Gele, Oncoscience	2014	47
Establishment and characterization of cetuximab resistant head and neck squamous cell carcinoma cell lines: focus on the contribution of the AP-1 transcription factor. Carolien Boeckx, Lina Blockx, Ken Op de Beeck, PubMed Central	2015	30
Expression profiling of migrated and invaded breast cancer cells predicts early metastatic relapse and reveals Krüppel-like factor 9 as a potential suppressor of invasive growth in breast cancer Ridha Limame, Ken Op de Beeck, Steven Van Laere, Oncoscience Breast OncologyInvasive GrowthInvasion Initiate MetastasisCancer BiologyTumor Biology	2014	29
Quantitative assessment of DNA hypermethylation in the inflammatory and non-inflammatory breast cancer phenotypes Ilse Van der Auwera, Catherine Bovie, Cecilia Svensson, Cancer Biology & Therapy	2009	26
A Phase II Study of the Combination of Endocrine Treatment and Bortezomib in Patients with Endocrine Resistant Metastatic Breast Cancer. X. Trinh, Steven Van Laere, Ines Deleu, Cancer Research	2009	18

Page 1